Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Corp. Accbt currently holds 29,006,924 shares of BRAINSTORM CELL THERAPEUTICS INC (BCLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Corp. Accbt has been a net buyer of BCLI stock. They have purchased $205.7K and sold $0 worth of shares.
Corp. Accbt's most recent insider trade was on Jan 23, 2011, when they sold 10,499,999 shares at $0.12 per share.
Corp. Accbt serves as Executive at BRAINSTORM CELL THERAPEUTICS INC (BCLI). They have executed 15 insider transactions totaling $205.7K over their tenure at the company.
Corp. Accbt holds the position of Executive at BRAINSTORM CELL THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Corp. Accbt has shown a buying trading pattern, with $205.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Corp. Accbt was on Jan 23, 2011, when they sold $1.3M worth of BCLI shares. This transaction involved 10,499,999 shares at $0.12 per share.
Corp. Accbt currently owns 29,006,924 shares of BRAINSTORM CELL THERAPEUTICS INC (BCLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Corp. Accbt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Corp. Accbt has 15 Form 4 filings on record as an insider at BRAINSTORM CELL THERAPEUTICS INC.
Set alerts for Corp. Accbt and 40,000+ other insiders.